The powerful trypanocidal activity of certain phenanthridinium compounds was first demonstrated by Browning and his collaborators in 1938 (Browning, Morgan, Robb, and Walls, 1938;Walls, 1947a; Browning, 1949). This activity is highly specific against African bovine trypanosomiasis caused by T. congolense and T. vivax. A single dose is usually effective and, in spite of local irritant action and the occasional late toxic effects observed in some districts, several million doses have been given. The drugs have thus gained a place in the treatment of a disease for which radical cure was previously difficult to achieve.At the time the work described in this paper started it had been demonstrated (Walls, 1947b) that high trypanocidal activity in the phenanthridinium series is a property of quaternary salts containing a primary amino-group in the 7-and a phenyl group in the 9-position; the activity is much enhanced by the presence of a second primary amino-group, 2: 7-diamino-9-phenyl-10-methylphenanthridinium bromide (dimidium bromide) being particularly effective. Compounds with the amino-group in the 3-position are less active. Our work was designed to test these conclusions further, and if possible to extend them. The investigations fall into five main groups:(a) To establish whether the 7-position represents the optimum location for the first primary amino-group.(b) To determine the effect of variation of the 9-substituent and, in particular, whether the high activity of the 2: 7-diamino-compounds is associated with other 9-substituents than phenyl.(c) To determine the effect of modifying the primary amino-groups.(d) To determine the effect of alkoxyl groups. (e) To consider the relation between trypanocidal and antibacterial activity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.